Inhalation Drug Delivery: Considerations for Toxicology and Pharmacology Research, New Webinar Hosted by Xtalks
TORONTO, October 8, 2018 (Newswire.com) - Drug delivery to the lungs in both the clinical and non-clinical setting is a unique combination of formulation, delivery device and the system/model that the drug is being delivered to. Throughout different stages of drug development, the requirements for inhalation drug delivery change and the delivery system must change/evolve to meet the needs at each stage. Early proof-of-concept studies may make use of rodent species, simple formulations that minimize excipients, ‘off-the-shelf’ delivery devices and may utilize direct to the lungs as an option.
Pharmacology experiments utilize a balance of robust formulation/delivery systems with translational animal models. In contrast, IND and NDA enabling studies utilize large and small animals, well defined/developed formulations, devices designed to support the proposed clinical program and inhalation delivery to the lungs.
This live webinar, upcoming on Wednesday, October 24, 2018 at 10am EDT (3pm BST/UK), will cover the merger of formulations, devices and models throughout the development process with a focus on the risks/benefits of different options at different development time points.
Featured speakers from Lovelace Biomedical including Philip Kuehl, PhD, Scientist and Director of Scientific Core Laboratories and Edward Barrett, PhD, Senior Scientist and Senior Director of Pharmacology will cover:
- An introduction to the combination of formulation, translational non-clinical models and drug development
- Inhalation drug delivery throughout drug development
- Translatable pharmacology models in respiratory disease
- Toxicology study designs
- How inhalation drug development can be accomplished
For more information about this complimentary webinar visit: Inhalation Drug Delivery: Considerations for Toxicology and Pharmacology Research.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Tel: +1 (416) 977-6555 ext 352
Categories: Pharmaceuticals and Biotech
Tags: Drug Discovery and Development, Inhalation Drug Delivery, Life Sciences, Lovelace Biomedical, Medical Device, Medical Device Design, Pharmaceutical, Pharmacology, Preclinical, Toxicology, Xtalks